Transcranial Alternating Current Stimulation in Cerebral Palsy (BOOSTTACS)
- Disease/Condition
- Cerebral Palsy
- Drug/Device/Intervention
- transcranial Alternating Current Stimulation
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- IRCCS Eugenio Medea
- Location
- Bosisio Parini, Italy
- Phase
- N/A
- Start date
- Apr 15, 2024
- End date
- May 14, 2026
- Enrollment
- 44 participants
Assisting Hand Assessment (AHA),Box and Block Test (BBT),Visuomotor task
The present study aims to assess, through a randomized controlled trial (RCT), the efficacy
 of transcranial alternating current stimulation (tACS) in enhancing the functional changes
 due to an intensive motor training in children and adolescents with Cerebral Palsy (CP).
 Particularly, in two different groups active or sham tACS will be paired with the Hand-Arm
 Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) and we will assess the
 effects on the upper limbs motor ability and daily functioning in 6 to 17 years old patients
 with CP having mild-to moderate upper limb deficits. The investigators hypothesized that,
 thanks to the intensive bimanual training, both the active and the sham group will improve in
 motor functioning. However, in light of findings showing that tACS effectively improves motor
 learning, the investigators hypothesized that active tACS might improve in a greater and more
 lasting extent than sham tACS the motor functioning. Moreover, as suggested by previous
 studies investigating the effect of non-invasive brain stimulation (NIBS) in pediatric
 population, the investigators expected that the treatment will be safe and well tolerated.
 Such a result would encourage the use of NIBS to boost the rehabilitative training of motor
 abilities in children and adolescents with CP.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06372041
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06372041 through Pure Global AI's free database. This phase not specified trial is sponsored by IRCCS Eugenio Medea and is currently Not yet recruiting. The study focuses on Cerebral Palsy. Target enrollment is 44 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.